Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
42,424,296
-
Share change
-
-2,351,821
-
Total reported value
-
$103,944,627
-
Price per share
-
$2.45
-
Number of holders
-
86
-
Value change
-
-$6,424,568
-
Number of buys
-
38
-
Number of sells
-
33
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q4 2015
As of 31 Dec 2015,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,424,296 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FEDERATED INVESTORS INC /PA/, Broadfin Capital, LLC, Consonance Capital Management LP, VANGUARD GROUP INC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, BlackRock Fund Advisors, SPHERA FUNDS MANAGEMENT LTD., and STATE STREET CORP.
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.